Skip to content

The Affection of Two Chest Management for Enhanced Recovery Program After Video-assisted Thoracoscopic Lobectomy.

Comparison of the Results of Two Chest Tube Management During an Enhanced Recovery Program After Video-Assisted Thoracoscopic Lobectomy.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03598296
Enrollment
60
Registered
2018-07-26
Start date
2018-07-28
Completion date
2018-10-27
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Tube

Keywords

ERAS(Enhanced Recovery After Surgery), Video-assisted thoracoscope lobectomy, Non-Small Cell Lung Cancer (NSCLC), Chest tube

Brief summary

Comparing the influences of different chest tube managements for enhanced recovery program after video-Assisted thoracoscopic lobectomy.

Detailed description

The Enhanced Recovery Program has a series of observation data contains hospitalization days, adverse events, drainage, extubation, visual analogue scale(VAS) scores and the number of analgesic using.The investigators plan to enroll 60 patients and divide them into two groups to compare the influences of different chest tube managements for enhanced recovery program after video-assisted thoracoscopic lobectomy.

Interventions

OTHERLarge size tube

Patients in Group A are inserted the large size tube (28F).

OTHERDrainage ball

Patients in Group B are inserted the small-bore tube connects with a negative pressure ball(drainage ball).

Sponsors

The First Affiliated Hospital of Soochow University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Total 60 patients accept video-Assisted thoracoscopic lobectomy are divided into two groups(Group A and Group B) equally and randomly.Different group takes different chest tube managements.

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Only single lesion on the targeted lobe * Considered as invasive carcinoma by preoperative computed tomography (CT) or -diagnosed by intraoperative pathology * Patients have signed informed consent.

Exclusion criteria

* Patients have critical basic disease(diabetes and hypertension). * Patients who lung function cannot undertake the lobectomy. * The lesion has the possibility of metastasis. * Finding serious adhesion to pleura during operation

Design outcomes

Primary

MeasureTime frameDescription
Hospitalization daysFrom the first days after surgery to discharge,up to 4 weeks.The numbers of days of patients stay in the hospital after surgery

Secondary

MeasureTime frameDescription
VAS scoresPain is measured by VAS on the first 24 hours of after operation and the first 24 hours after tube removing.VAS(Visual Analogue Score) is a method to value the degree of patient's pain after surgery.This method has a scale range from 1 to 10.Patient chose a number from it to represent his(her) pain.The 1 represents painless and the 10 represents sever pain which he(she) unable to bear. The pain is increasing with the increasing of number.
AnalgesicsCounting the total analgesics using times through study completion, an average of 3 months.The number of analgesics using after surgery.
DrainageMeasure the volume every 24 hours,up to 4 weeksThe total volume of fluid.
Pulmonary recruitmentThe first 24 hours after surgery and 8 hours before leaving hospital.Chest X-Ray
Adverse eventCounting the times of adverse events through study completion, an average of 3 months.Air-leakage or seepage from the surrounding of tube.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026